PACS Group (NYSE:PACS) Stock: Insider Michelle Renee Lewis Sells 2,364 Shares

01 Nov 2026, 04:53 by Jessica Moore · The Cerbat Gem

PACS Group, Inc. (NYSE:PACS – Get Free Report) CAO Michelle Lewis sold 2,364 shares of the stock in a transaction that occurred on Thursday, October 29th. The stock was sold at an average price of $50.04, for a total transaction of $118,294.56. Following the completion of the sale, the chief accounting officer directly owned 343,510 shares of the company’s stock, valued at $17,189,240.40. This represents a 0.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Michelle Renee Lewis also recently made the following trade(s):

On Wednesday, October 28th, Michelle Lewis sold 9,464 shares of PACS Group stock. The stock was sold at an average price of $50.12, for a total transaction of $474,335.68.

PACS Group Price Performance

NYSE PACS opened at $47.76 on Friday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.21. PACS Group, Inc. has a 12 month low of $10.31 and a 12 month high of $50.38. The stock has a market cap of $7.56 billion, a price-to-earnings ratio of 27.77, a PEG ratio of 1.49 and a beta of -0.08. The company’s 50 day moving average is $44.21 and its two-hundred day moving average is $39.79.

PACS Group (NYSE:PACS – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.09. The business had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. As a group, research analysts anticipate that PACS Group, Inc. will post 2.13 earnings per share for the current year.

Hedge Funds Weigh In On PACS Group

Institutional investors have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP increased its stake in PACS Group by 370.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company’s stock worth $25,051,000 after acquiring an additional 614,250 shares during the last quarter. Sei Investments Co. boosted its position in shares of PACS Group by 7.4% during the 1st quarter. Sei Investments Co. now owns 370,501 shares of the company’s stock valued at $11,900,000 after acquiring an additional 25,462 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its position in shares of PACS Group by 44.6% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company’s stock valued at $9,274,000 after acquiring an additional 89,067 shares during the last quarter. Bank of New York Mellon Corp bought a new position in shares of PACS Group during the 2nd quarter valued at approximately $8,196,000. Finally, Corient Private Wealth LP grew its holdings in shares of PACS Group by 1.8% in the second quarter. Corient Private Wealth LP now owns 152,846 shares of the company’s stock valued at $6,517,000 after purchasing an additional 2,680 shares in the last quarter.

Trending Headlines about PACS Group

Here are the key news stories impacting PACS Group this week:

Neutral Sentiment: CEO Jason Murray, Director Mark Hancock, and Chief Accounting Officer Michelle Lewis collectively sold approximately 33,935 shares for about $1.70 million at prices near $50 per share. However, the transactions were executed under pre-arranged 10b5-1 plans, and the executives continue to hold substantial positions. The sales therefore appear more consistent with scheduled diversification or liquidity needs than a clear indication of weakening confidence. Mark Hancock insider-trading filing Jason Murray insider-trading filing Michelle Lewis insider-trading filing
Negative Sentiment: A shareholder-focused law firm issued an alert encouraging PACS investors to contact the Shareholders Foundation regarding a potential lawsuit. The notice provides no confirmed allegations or details about the case in the supplied report, so the immediate financial impact is uncertain, but litigation-related headlines can create additional volatility and concern around the stock. PACS shareholder lawsuit alert

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on PACS shares. Weiss Ratings upgraded shares of PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, October 8th. Oppenheimer increased their price target on PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a research note on Monday, August 10th. UBS Group raised their price target on PACS Group from $57.00 to $60.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Truist Financial set a $62.00 price target on PACS Group in a report on Wednesday, September 2nd. Finally, JPMorgan Chase & Co. lifted their target price on PACS Group from $47.00 to $58.00 and gave the company an “overweight” rating in a research note on Friday, September 4th. Five equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $58.80.

Check Out Our Latest Research Report on PACS Group

About PACS Group

(Get Free Report)

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.